UIC
MDT icon

Uniplan Investment Counsel’s Medtronic MDT Stock Holding History

Uniplan Investment Counsel’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Sell
13,518
-298
-2% -$28.5K 0.12% 130
2025
Q4 		$1.33M Sell
13,816
-150
-1% -$14.6K 0.13% 138
2025
Q3 		$1.33M Buy
+13,966
New +$1.28M 0.13% 135

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Uniplan Investment Counsel's MDT Position: Q1 2026 in Review

Uniplan Investment Counsel reduced its Medtronic (MDT) stake by 2.2% in Q1 2026, selling an estimated $28.5K and leaving 13,518 shares worth $1.17M. The position accounts for 0.12% of the portfolio, ranked #130.

Uniplan Investment Counsel first reported a position in MDT in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.33M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Uniplan Investment Counsel held 13,518 shares of Medtronic worth $1.17M as of Q1 2026.
  • Uniplan Investment Counsel sold 298 Medtronic shares in Q1 2026, an estimated $28.5K.
  • Medtronic made up 0.12% of Uniplan Investment Counsel's portfolio in Q1 2026, its #130 holding.
  • Uniplan Investment Counsel first reported a position in Medtronic in Q3 2025 and has held it in 3 quarters since.
  • Uniplan Investment Counsel's Medtronic position peaked at $1.33M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.